Oruka Therapeutics (ORKA) Tax Provisions (2018 - 2020)

Oruka Therapeutics' Tax Provisions history runs 3 years deep, the most recent figure standing at -$9000.0 for Q2 2020.

• In Q2 2020, Tax Provisions rose 66.67% year-over-year to -$9000.0; the TTM figure through Dec 2020 stood at -$25000.0 (up 85.03% YoY), while the FY2020 annual figure was -$9000.0, up 94.61% from the prior year.
• Tax Provisions was -$9000.0 for Q2 2020 at Oruka Therapeutics, up from -$16000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of -$9000.0 in Q2 2020 to a low of -$82000.0 in Q1 2019.
• Historically, Tax Provisions has averaged -$34500.0 across 3 years, with a median of -$29000.0 in 2018.
• The sharpest annual moves came in 2019 and 2020: Tax Provisions tumbled 35.48% in 2019, then surged 66.67% in 2020.
• A 3-year view of Tax Provisions shows it stood at -$31000.0 in 2018, then surged by 48.39% to -$16000.0 in 2019, then surged by 43.75% to -$9000.0 in 2020.
• The last three Tax Provisions figures came in at -$9000.0 (Q2 2020), -$16000.0 (Q4 2019), and -$42000.0 (Q3 2019), per Business Quant data.